Clinical Trial: A Study to Assess New Formulations of TEV-56286
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Participants
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Randomized, Crossover Study to Assess the Comparative Bioavailability of New TEV-56286 Formulations Compared to a Reference TEV-56286 Capsule Formulation Following Single-Dose Administr
Brief Summary:
The primary objective of the study is to assess the relative bioavailability of TEV-56286 test formulations compared to TEV-56286 reference product in healthy adult participants.The secondary objective is to evaluate the safety and tolerability of TEV-56286.The planned duration for each participant is approximately 70 days which includes a 45 day screening period.
Read more